66. IgA nephropathy Clinical trials / Disease details

Clinical trials : 255 / Drugs : 255 - (DrugBank : 79) / Drug target genes : 35 - Drug target pathways : 137

5 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03218852 (ClinicalTrials.gov)	December 2016	7/12/2016	Extended Follow-up of Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy	An Extended Follow-up of the Prospective Randomized, Controlled, Open-labeled Trial of Prednisone Plus Cyclophosphamide in Patients With Advanced Stage IgA Nephropathy	IgA Nephropathy	Drug: prednisone and cyclophosphamide;Drug: prednisone alone	Guangdong General Hospital	NULL	Active, not recruiting	18 Years	70 Years	All	133	Phase 4	China
2	NCT03015974 (ClinicalTrials.gov)	January 2016	3/1/2017	Registry of IgA Nephropathy in Chinese Children	Registry of IgA Nephropathy in Chinese Children	IgA Nephropathy;Proteinuria in Nephrotic Range;Immunosuppressive Treatment	Drug: Corticosteroid;Drug: Cyclophosphamide;Drug: Mycophenolate mofetil;Drug: Dipyridamole;Drug: ACE Inhibitor or Angiotensin receptor antagonist	Peking University First Hospital	Nanjing PLA General Hospital;Beijing Children's Hospital;Central South University;The Children's Hospital of Zhejiang University School of Medicine;First Affiliated Hospital, Sun Yat-Sen University;Tongji Hospital;Hunan Children's Hospital;Shanghai Children's Hospital;Nanjing Children's Hospital;Children's Hospital of Chongqing Medical University;Shandong Provincial Hospital;Fuzhou General Hospital;Second Affiliated Hospital of Wenzhou Medical University;Children's Hospital of Hebei Province;Guangzhou Women and Children's Medical Center;Jiangxi Province Children's Hospital;Guangzhou First People's Hospital;Xian Children's Hospital;Capital Institute of Pediatrics, China;First Hospital of Jilin University;Wuhan Women and Children's Medical Center;Tianjin Children's Hospital;Chengdu Women's and Children's Central Hospital;The First People's Hospital of Yunnan	Recruiting	1 Month	18 Years	All	1200		China
3	NCT01758120 (ClinicalTrials.gov)	December 2012	12/12/2012	Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy	A Prospective Randomized, Controlled, Open-labeled Trial of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy	IgA Nephropathy	Drug: prednisone plus cyclophosphamide;Drug: Prednisone alone	Guangdong General Hospital	NULL	Active, not recruiting	18 Years	70 Years	All	135	Phase 4	China
4	EUCTR2007-000871-41-DE (EUCTR)	24/01/2008	27/11/2007	Supportive versus Immunosuppressive Therapy for the treatment Of Progressive IgA Nephropathy - STOP IgAN	Supportive versus Immunosuppressive Therapy for the treatment Of Progressive IgA Nephropathy - STOP IgAN	IgA nephropathy (IgAN) as the most common type of glomerulonephritis. MedDRA version: 16.1;Level: PT;Classification code 10021263;Term: IgA nephropathy;System Organ Class: 10038359 - Renal and urinary disorders	Product Name: Azathioprine INN or Proposed INN: AZATHIOPRINE Product Name: Cyclophosphamid INN or Proposed INN: CYCLOPHOSPHAMIDE Product Name: Prednisolon INN or Proposed INN: PREDNISOLONE Product Name: Methylprednisolon INN or Proposed INN: METHYLPREDNISOLONE Product Name: supportive therapy	RWTH Aachen	NULL	Not Recruiting			Female: yes Male: yes	148		Germany
5	NCT00301600 (ClinicalTrials.gov)	January 2003	10/3/2006	Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA Nephropathy	Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA Nephropathy	IGA Nephropathy	Drug: Mycophenolate mofetil	Nanjing University School of Medicine	NULL	Completed	12 Years	65 Years	Both	40	N/A	China